Search Within
Document Type
67-71-0
Applied Filters:
Keyword:'67-71-0'
Showing 1-30 of 218 results for "67-71-0" within Technical Documents
Chemical compatibility of Mobius®components
Acetone 67-64-1 100% R L NR NR NR NR NR L L
Ammonium
Persulfate
7727-54-0 all aqueous
concentrations
R R L L L R R ND R
Ammonium
The Effective Use of Protein Kinase Inhibitors
99 98 103 104 101 67 95 77 101 95 82 99 67 96 90 76 93 63 98 105 83 69
90 100 58 60 1 0 0 0 80 36 102 110 77 70 93 99 21
Periodic Table of the Elements - Certipur ICP multi-element standards according to USP <232> - EMD
5, 7
[Xe] 4f145d106s26p5
86 *222.02 –71
–61.7
Rn
2
[Xe] 4f145d106s26p6
102.91 31
45
2
1966 4
3727 5
1.5 6
[Kr] 4d85s1
The Effective Use of Protein Kinase Inhibitors
99 98 103 104 101 67 95 77 101 95 82 99 67 96 90 76 93 63 98 105 83 69
90 100 58 60 1 0 0 0 80 36 102 110 77 70 93 99 21
NovAseptic® Valve Inductive Position Indicator Unit
Degree of Protection IP 67
Cable Length between Detectors and Socket Connection 20 cm (approx.)
Additional Information
Surface Roughness Smooth
Environment Temperature 0 to 40 ºC (32 to 104 ºF
Periodic table A4
Unknown title
S
ta
n
d
:
0
1
/2
0
1
7
W
.2
8
0
7
1
8
The life science business of Merck
LABORATORY NOTEBOOK ISSUANCE PAGE
8.
49
18
0.
95
18
3.
84
18
6.
21
19
0.
23
19
2.
22
(2
27
)
(2
65
)
(2
68
)
(2
71
)
(2
70
)
(2
77
)
(2
76
)
LABORATORY NOTEBOOK ISSUANCE PAGE
8.
49
18
0.
95
18
3.
84
18
6.
21
19
0.
23
19
2.
22
(2
27
)
(2
65
)
(2
68
)
(2
71
)
(2
70
)
(2
77
)
(2
76
)
LABORATORY NOTEBOOK ISSUANCE PAGE
8.
49
18
0.
95
18
3.
84
18
6.
21
19
0.
23
19
2.
22
(2
27
)
(2
65
)
(2
68
)
(2
71
)
(2
70
)
(2
77
)
(2
76
)
Chromatographic Purification of Plasmid DNA
)
350
0 21 43 5 6 7 8 9 10 11
300
200
250
100
150
50
0
Retention time (minutes)
DAD: Signal A, 260 nm/Bw: 4 nm
Product Information Sheet - A2385
A.B. and Leyland-Jones, B., Biochemistry
of azacitidine: a review. Cancer Treatment
Reports, 71(10), 959-964 (1987).
3. Taylor. S.M. et al., 5-Azacytidine, DNA
methylation, and differentiation
Periodic table Poster
106.42 1554.8
2963
1.30Pd
0, 2, 4
[Kr] 4d10
47 107.87 961.78
2162
1.42Ag
1, 2
[Kr] 4d105s1
48 112.41 321.07
767
1.46Cd
2
[Kr] 4d105s2
57–71
Lanthanides
Lantánidos
72 178.49
Specification Sheet: NovAseptic® Mixer Drive Unit, GMP ATEX
ATEX
AX1/41 281 (11.06) 145 (5.71) 123 (4.84) 71 (2.80) –057 131 (5.16) –058 171 (6.73) –059 GMP100 ATEX
AX5/41 281 (11.06) 145 (5.71) 123 (4.84) 71 (2.80) –060 131 (5.16) –061 171 (6.73) –062 GMP500
User Guide-RAB1052
Culture Supernatants
1:2
Average % of Expected 72 71 74
Range (%) 67-76 68-77 69-78
1:4
Average % of Expected Range 74 72 75
Range (%) 70-77 67-78 71-78
4
RAB1052pis Rev 08/24
User Guide-RAB1295
Culture Supernatants
1:2
Average % of Expected 71 77 79
Range (%) 68-74 67-87 73-84
1:4
Average % of Expected Range 71 82 83
Range (%) 67-74 89-112 79-88
4
RAB1295pis Rev 08/24
Mobius®MIX Single-Use Mixing Systems Specification Sheet
g
-
6
0"
+
1
,5
"
S
te
ri
le
n
ze
™
T
C
N
ee
d
le
F
re
e
S
am
p
le
P
or
t
Immunomonitoring using the Scepter 2.0 Cell Counter and Software Pro
42 35 37
2 Lymphocyte 68 72 71
Monocyte 32 28 29
3 Lymphocyte 66 69 71
Monocyte 34 31 29
4 Lymphocyte 62 67 64
Monocyte 38 33 36
5 Lymphocyte 64
MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors
00
0
7,
00
0
8,
00
0
9,
00
0
0
50
,0
00
10
0,
00
0
15
0,
00
0
20
0,
00
0
25
0,
00
0
30
0,
00
010 10
0
1,
00
0
10
,0
00
10
0,
00
0
10 10
0
1,
00
0
10
,0
00
Fast GC-A Practical Guide for Increasing Sample Throughput without Sacrificing Quality
Phenanthrene-d10 (I.S.)
64. Phenanthrene
65. Anthracene
66. Carbazole
67. Di-n-butyl phthalate
68. Fluoranthene
69. Benzidine
70. Pyrene
71. Terphenyl-d14 (surr.)
72. 3,3’-Dimethylbenzidine
73. Butylbenzyl
User Guide-RAB0190
108
Range (%) 115-135 119-134 101-116
1:4
Average % of Expected Range 81 79 101
Range (%) 71-90 67-85 85-117
4
RAB0190pis Rev 08/24
Reproducibility
Intra-Assay CV%: <10%
Product Information Sheet-RAB0245
Plasma 92 71-134
Cell Culture Supernatants 104 79-120
Linearity
Sample Type Serum Plasma Cell Culture Supernatants
1:2
Average % of Expected 118 108 110
Range (%) 110-126 67-122 102-118
User Guide-RAB0190
108
Range (%) 115-135 119-134 101-116
1:4
Average % of Expected Range 81 79 101
Range (%) 71-90 67-85 85-117
4
RAB0190pis Rev 08/24
Reproducibility
Intra-Assay CV%: <10%
User Guide-RAB0245
Plasma 92 71-134
Cell Culture Supernatants 104 79-120
Linearity
Sample Type Serum Plasma Cell Culture Supernatants
1:2
Average % of Expected 118 108 110
Range (%) 110-126 67-122 102-118
FcFusionProteinSeparation
79
4
7.
47
8
7.
83
3
8.
71
8
9.
41
2
9.
92
9
10
.5
39
10
.8
13
11
.3
77
12
.0
42
12
.5
16
12
.7
59
12
.9
71
Enhanced Sensitivity Immunogenicity (ADA) Assay - Next Generation SMC™ Technology
F
23.44 ng/mL
B + F
0 1 1 1 1
0.05 1 2 1 1
0.19 2 2 1 1
0.76 3 3 2 2
3.05 6 9 7 8
12.00 10 25 28 29
49 19 44 96 142
195 41
Relationship of MC-Media Pad E. coli & Coliform Plate Results with the Most Probable Number Method
x= (y-0.07)/1.0 MPN/g
66 1.820 1.733 54.063
67 1.826 1.739 54.843
68 1.833 1.745 55.622
69 1.839 1.751 56.401
70 1.845 1.757 57.179
71 1.851 1.763 57.957
72 1.857 1.769 58.734
73
Product Information Sheet - C1139
MeOH @ 21°C)
D1641 39156-67-7 White powder C29H37NO5 481.64 198-203°C
C1139 56144-22-0 Faint yellow powder C28H37NO4 451.61 137-139°C +42.2 (0.97 g/100 ml
CH3OH)
D6016 14110-71-5 White powder C29H37NO5
Product Information Sheet - C0138
MeOH @ 21°C)
D1641 39156-67-7 White powder C29H37NO5 481.64 198-203°C
C1139 56144-22-0 Faint yellow powder C28H37NO4 451.61 137-139°C +42.2 (0.97 g/100 ml
CH3OH)
D6016 14110-71-5 White powder C29H37NO5
Polygard® CN Filters
)
Diameter: 69 mm (2.75 in.) 69 mm (2.75 in.) 69 mm (2.75 in.)
Weight: 2.3 oz (67 g) 2.3 oz (67 g) 2.3 oz (67 g)
Filtration Area 17.7 cm2
Materials of Construction
Balancing Histone/Protein Acetylation-Gene Regulation and Cancer Therapy
rt
ic
le
O
r
d
e
r
:
1
.
8
0
0
.
3
2
5
.
3
0
1
0
T
e
c
h
n
i
c
a
l
S
e
r
v
i
c
e
Page 1 of 8